Apollo Device for Metastatic Breast Cancer (MBC)

Completed · Not applicable

Conditions studied: Fatigue, Metastatic Breast Carcinoma

In brief

This is a single-arm, open label pilot intervention study with outcomes measured by electronic survey and chart review evaluating a wearable device called Apollo, which is similar to a FitBit but emits vibrations. Our primary objective is to assess whether or not Apollo can help with symptoms of fatigue and pain in patients with Metastatic Breast Cancer (MBC).

Key facts

Study ID

NCT04983342

Run by

Margaret Quinn Rosenzweig

People needed

27

Starts

2021-02-01

Expected to finish

2022-08-09

Last updated by the study team

2024-06-21

Who can join

Age: 18 and older, up to 100. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Metastatic breast cancer diagnosis
• Fatigue score of 4 or greater at last clinic visit

You may not qualify if…

• Not able to read and understand English
• Use of Beta Blockers,
• Use of medications for serious mental illness

Where it is running

• Magee Womens Hospital — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.